Literature DB >> 11920461

Coexpression of ephrin-Bs and their receptors in colon carcinoma.

Wenbiao Liu1, Syed A Ahmad, Young D Jung, Niels Reinmuth, Fan Fan, Corazon D Bucana, Lee M Ellis.   

Abstract

BACKGROUND: The erythropoietin-producing hepatoma amplified sequence (Eph) family is the largest subfamily of receptor tyrosine kinases (RTKs). The Ephs (receptors) bind to specific cell-bound ligands, called ephrins. The binding of this ligand-receptor system is dependent on cell-cell interactions. The ephrin-Eph system is important in embryologic development and differentiation of the nervous and vascular systems. In the current study, the authors hypothesized that ephrins may play a role in the growth and development of colon carcinoma and may be expressed differentially in normal and malignant colonic tissues.
METHODS: Reverse transcriptase-polymerase chain reaction (RT-PCR), Northern Blot analyses, and immunohistochemistry were used to examine 11 colon carcinoma cell lines and 20 human colon carcinoma specimens with adjacent uninvolved mucosa for the expression of EphB and ephrin-B family members.
RESULTS: EphB2, EphB3, and EphB4 mRNA expression and ephrin-B2 mRNA expression was detected in all the cell lines and colon carcinoma specimens examined. Immunohistochemical analysis showed that ephrin-B2 had higher expression in the colon carcinoma specimens studied than in adjacent normal mucosa. Ephrin-B2 and EphB4 most frequently were expressed on the luminal surface of colon carcinoma epithelium.
CONCLUSIONS: The results of the current suggest that the ephrin-Bs are expressed differentially in colon carcinoma and normal mucosa specimens and thus may play a role in the progression of colon carcinoma. Further studies are necessary to determine the functional role of ephrin-Bs in colon carcinoma angiogenesis and growth. Copyright 2002 American Cancer Society. DOI 10.1002/cncr.10122

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11920461     DOI: 10.1002/cncr.10122

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  36 in total

1.  Ephrin-A2 reverse signaling negatively regulates neural progenitor proliferation and neurogenesis.

Authors:  Johan Holmberg; Annika Armulik; Kirsten-André Senti; Karin Edoff; Kirsty Spalding; Stefan Momma; Rob Cassidy; John G Flanagan; Jonas Frisén
Journal:  Genes Dev       Date:  2005-02-15       Impact factor: 11.361

2.  Control of blood vessel identity: from embryo to adult.

Authors:  Tiffany T Fancher; Akihito Muto; Tamara N Fitzgerald; Dania Magri; David Gortler; Toshiya Nishibe; Alan Dardik
Journal:  Ann Vasc Dis       Date:  2008-02-15

Review 3.  Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression.

Authors:  Tura C Camilli; Ashani T Weeraratna
Journal:  Biochem Pharmacol       Date:  2010-03-06       Impact factor: 5.858

4.  DNA Methylation of the EphA5 Promoter Is Associated with Rat Congenital Hypothyroidism.

Authors:  Youjia Wu; Honghua Song; Baolan Sun; Meiyu Xu; Jinlong Shi
Journal:  J Mol Neurosci       Date:  2015-06-25       Impact factor: 3.444

5.  Identification of the Eph receptor pathway as a novel target for eicosapentaenoic acid (EPA) modification of gene expression in human colon adenocarcinoma cells (HT-29).

Authors:  Joanne F Doleman; John J Eady; Ruan M Elliott; Rob J Foxall; John Seers; Ian T Johnson; Elizabeth K Lund
Journal:  Nutr Metab (Lond)       Date:  2010-07-12       Impact factor: 4.169

6.  The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis.

Authors:  Georg Martiny-Baron; Philipp Holzer; Eric Billy; Christian Schnell; Joseph Brueggen; Mireille Ferretti; Niko Schmiedeberg; Jeanette M Wood; Pascal Furet; Patricia Imbach
Journal:  Angiogenesis       Date:  2010-08-29       Impact factor: 9.596

7.  Clinical implications of EphB4 receptor expression in pancreatic cancer.

Authors:  Man Li; Zuowei Zhao
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

8.  EphA2 up-regulation induced by deoxycholic acid in human colon carcinoma cells, an involvement of extracellular signal-regulated kinase and p53-independence.

Authors:  Zhongyou Li; Masamitsu Tanaka; Hideki Kataoka; Ritsuko Nakamura; Ravshanov Sanjar; Kazuya Shinmura; Haruhiko Sugimura
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-15       Impact factor: 4.553

9.  Epigenetic silencing of EphA1 expression in colorectal cancer is correlated with poor survival.

Authors:  N I Herath; J Doecke; M D Spanevello; B A Leggett; A W Boyd
Journal:  Br J Cancer       Date:  2009-03-10       Impact factor: 7.640

10.  Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung.

Authors:  Ji Un Kang; Sun Hoe Koo; Kye Chul Kwon; Jong Woo Park; Jin Man Kim
Journal:  BMC Cancer       Date:  2009-07-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.